World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 43 4859 4499 19 18 176 5666

Chang-Yuil Kang publications per year

The chart shows the history of publications by Chang-Yuil Kang between 1985 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Chang-Yuil Kang published across 41 years, from 1985 to 2025, averaging 4.8 papers a year. Output peaked at 36 publications in 2023. 13 of the 195 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1985 to 2025. Vertical axis: number of publications, 0 to 36. Peak 36 publications in 2023. 1985: 1 publication 1986: 3 publications 1987: 1 publication 1988: 2 publications 1989: 1 publication 1990: 2 publications 1991: 2 publications 1992: 2 publications 1993: 0 publications 1994: 1 publication 1995: 1 publication 1996: 0 publications 1997: 0 publications 1998: 1 publication 1999: 4 publications 2000: 2 publications 2001: 1 publication 2002: 2 publications 2003: 5 publications 2004: 7 publications 2005: 7 publications 2006: 3 publications 2007: 10 publications 2008: 8 publications 2009: 7 publications 2010: 6 publications 2011: 6 publications 2012: 9 publications 2013: 6 publications 2014: 8 publications 2015: 3 publications 2016: 4 publications 2017: 4 publications 2018: 6 publications 2019: 4 publications 2020: 9 publications 2021: 5 publications 2022: 3 publications 2023: 36 publications 2024: 5 publications 2025: 8 publications
1985 2025

195 publications in total across all disciplines

View publications per year as a table
Chang-Yuil Kang: publications per year, 1985 to 2025
Year Publications
1985 1
1986 3
1987 1
1988 2
1989 1
1990 2
1991 2
1992 2
1993 0
1994 1
1995 1
1996 0
1997 0
1998 1
1999 4
2000 2
2001 1
2002 2
2003 5
2004 7
2005 7
2006 3
2007 10
2008 8
2009 7
2010 6
2011 6
2012 9
2013 6
2014 8
2015 3
2016 4
2017 4
2018 6
2019 4
2020 9
2021 5
2022 3
2023 36
2024 5
2025 8
Total 195
Download as CSV

Chang-Yuil Kang publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Chang-Yuil Kang sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 172–181 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 176 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181 176
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Chang-Yuil Kang D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Chang-Yuil Kang sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 42–43 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 43 D-Index — 2nd percentile

2% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91 43
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Chang-Yuil Kang is affiliated with Seoul National University in South Korea. Their body of work spans several interrelated fields within biomedical science, with a focus on immunology, medicine, and microbiology.

The main fields of study in Kang's publications include:

  • Medicine
  • Immunology and Microbiology

More specifically, their research addresses subfields such as:

  • Immunology
  • Infectious Diseases
  • Oncology
  • Molecular Biology
  • Epidemiology

Their research interests cover a range of topics primarily centered on immune system function and disease, including:

  • Immunotherapy and Immune Responses
  • SARS-CoV-2 and COVID-19 Research
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Cervical Cancer and HPV Research
  • T-cell and B-cell Immunology
  • Vaccines and Immunoinformatics Approaches

Kang has published multiple papers in frequent venues, indicating established contributions within key journals:

  • Journal for ImmunoTherapy of Cancer
  • Journal of Clinical Oncology
  • Proceedings of the National Academy of Sciences
  • Vaccines
  • Frontiers in Immunology

Significant recent publications include:

  • "Type 17 immunity promotes the exhaustion of CD8+ T cells in cancer," 2021, Journal for ImmunoTherapy of Cancer
  • "Endogenous TLR2 ligand embedded in the catalytic region of human cysteinyl-tRNA synthetase 1," 2020, Journal for ImmunoTherapy of Cancer
  • "Phase I Study of a B Cell-Based and Monocyte-Based Immunotherapeutic Vaccine, BVAC-C in Human Papillomavirus Type 16- or 18-Positive Recurrent Cervical Cancer," 2020, Journal of Clinical Medicine
  • "IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials," 2024, Immune Network
  • "A critical role for Th17 cell-derived TGF-β1 in regulating the stability and pathogenicity of autoimmune Th17 cells," 2021, Experimental & Molecular Medicine

Frequent co-authors collaborating with Kang include:

  • Kwangsoo Shin
  • Myung Hwan Park
  • Bongju Park
  • Boyeong Song
  • Insu Jeon

The researcher's work collectively covers diverse aspects of immune cell function, cancer immunotherapy, vaccine development, and response mechanisms to infectious diseases such as COVID-19. This multidisciplinary approach situates Kang's contributions at the interface of immunology, oncology, and infectious disease research.

Best Publications

  • A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model

    Hyun-Jeong Ko;Yeon-Jeong Kim;Yun-Sun Kim;Woo-Sung Chang

  • Synthesis and Evaluation of 1,2,3-Triazole Containing Analogues of the Immunostimulant α-GalCer

    Taeho Lee;Minjae Cho;Sung-Youl Ko;Hyun-Jun Youn

  • α-Galactosylceramide Can Act As a Nasal Vaccine Adjuvant Inducing Protective Immune Responses against Viral Infection and Tumor

    Sung Youl Ko;Hyun Jeong Ko;Woo Sung Chang;Se Ho Park

  • Cutting edge: Programmed death-1/programmed death ligand 1 interaction regulates the induction and maintenance of invariant NKT cell anergy.

    Woo-Sung Chang;Ji-Yeon Kim;Yeon-Jeong Kim;Yun-Sun Kim

  • Lipid raft proteome reveals ATP synthase complex in the cell surface

    Tae-Jung Bae;Min-Sik Kim;Jun-Woo Kim;Bong-Woo Kim

  • Glucocorticoid-induced tumor necrosis factor receptor-related protein co-stimulation facilitates tumor regression by inducing IL-9-producing helper T cells

    Il Kyu Kim;Byung Seok Kim;Choong Hyun Koh;Jae Won Seok

  • IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours.

    Hyungseok Seo;Insu Jeon;Byung-Seok Kim;Myunghwan Park

  • Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted Into Immunogenic APCs With the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine

    Hyun-Jeong Ko;Jung-Mi Lee;Yeon-Jeong Kim;Yun-Sun Kim

  • Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide.

    Chang-Yuil Kang;T. K. Brunck;T. Kieber-Emmons;J. E. Blalock

  • Characterization of age‐associated exhausted CD8+ T cells defined by increased expression of Tim‐3 and PD‐1

    Kyoo‐A Lee;Kwang‐Soo Shin;Ga‐Young Kim;You Chan Song

  • A single intranasal immunization with inactivated influenza virus and α-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system

    Hyun-Jun Youn;Sung-Youl Ko;Kyoo-A. Lee;Hyun-Jeong Ko

  • IFN-γ-STAT1 signal regulates the differentiation of inducible Treg: Potential role for ROS-mediated apoptosis

    Jae-Hoon Chang;Yeon-Jeong Kim;Seung-Hee Han;Chang-Yuil Kang

  • Evidence for non-V3-specific neutralizing antibodies that interfere with gp120/CD4 binding in human immunodeficiency virus 1-infected humans.

    Chang Yuil Kang;Peter Nara;Soulaima Chamat;Vince Caralli

  • Optimization of Codon Usage Enhances the Immunogenicity of a DNA Vaccine Encoding Mycobacterial Antigen Ag85B

    Hyun Jeong Ko;Sung Youl Ko;Yeon Jeong Kim;Eun Gae Lee

  • Conversion of Th2 memory cells into Foxp3+ regulatory T cells suppressing Th2-mediated allergic asthma.

    Byung Seok Kim;Il Kyu Kim;Young Jun Park;Yun Sun Kim

  • Anticancer agent comprising anti-PD-1 antibody or anti-PD-L1 antibody

    Chang Yuil Kang;Woo Sung Chang;Ji Yeon Kim;Dong-Hyeon Kim

  • The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment.

    Jung-Mi Lee;Jeong-Hwan Seo;Yeon-Jeong Kim;Yun-Sun Kim

  • Interaction of the C-terminal Domain of p43 and the α Subunit of ATP Synthase ITS FUNCTIONAL IMPLICATION IN ENDOTHELIAL CELL PROLIFERATION

    Sun Young Chang;Sang Gyu Park;Sunghoon Kim;Chang Yuil Kang

  • 4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation.

    Dong-Hyeon Kim;Woo-Sung Chang;Yoon-Sook Lee;Kyoo-A Lee

  • Roles of NKT cells in cancer immunotherapy

    Eun-Ah Bae;Hyungseok Seo;Il-Kyu Kim;Insu Jeon

  • CD1d-Restricted T Cells License B Cells to Generate Long-Lasting Cytotoxic Antitumor Immunity In vivo

    Yeonseok Chung;Byung Seok Kim;Yeon Jeong Kim;Hyun Jeong Ko

  • An NKT-mediated autologous vaccine generates CD4 T-cell-dependent potent antilymphoma immunity

    Yeonseok Chung;Hong Qin;Chang Yuil Kang;Sanghee Kim

  • A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity.

    Kyoo-A Lee;Min-Hee Kang;Yoon-Sook Lee;Yeon-Jeong Kim

Frequent Co-Authors

Yeonseok Chung
Yeonseok Chung Seoul National University
Sanghee Kim
Sanghee Kim Seoul National University
Mi-Na Kweon
Mi-Na Kweon University of Ulsan
Peter L. Nara
Peter L. Nara Iowa State University
Byoung S. Kwon
Byoung S. Kwon Tulane University
Eun-Kyung Kim
Eun-Kyung Kim Yonsei University
Chen Dong
Chen Dong Tsinghua University
Sang-Nae Cho
Sang-Nae Cho Yonsei University
Doo Hyun Chung
Doo Hyun Chung Seoul National University
Thomas Kieber-Emmons
Thomas Kieber-Emmons University of Arkansas for Medical Sciences

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various advanced healthcare careers, often requiring further specialization. For those interested in nursing pathways, exploring affordable educational options is crucial. Many students consider cheap psych np programs to balance quality learning and cost-effectiveness.

Once qualified, understanding potential earnings helps set realistic career goals. The how much do dnps make resource offers valuable insights into salary variations by state, aiding informed decisions for nurse practitioners with a Doctor of Nursing Practice degree.

Career flexibility is another important consideration. Professionals aiming to shift focus can explore pathways like transitioning from one specialization to another. For example, transitioning from an FNP to acute care NP role is well-documented and supported through structured guidance, which you can find in fnp to acnp resources.

For those looking to accelerate their nursing credentials, accelerated programs are a great option. The selection of nurse practitioner accelerated program options online provides flexible pathways to quickly advance in the nursing field, complementing immunology expertise with practical patient care skills.

Best Scientists Citing Chang-Yuil Kang

Trending Scientists

Recently Published Articles